agilon health (NYSE:AGL) Given New $2.00 Price Target at TD Cowen

agilon health (NYSE:AGL) had its price objective trimmed by TD Cowen from $6.00 to $2.00 in a research note published on Monday morning,Benzinga reports. The firm currently has a hold rating on the stock.

Several other research analysts have also issued reports on AGL. Barclays decreased their price target on shares of agilon health from $5.00 to $2.00 and set an “underweight” rating for the company in a research note on Monday. Benchmark reiterated a “buy” rating and issued a $9.00 price target on shares of agilon health in a research note on Thursday, August 8th. Evercore ISI decreased their price target on shares of agilon health from $7.00 to $4.00 and set an “in-line” rating for the company in a research note on Tuesday, October 8th. Royal Bank of Canada reiterated an “outperform” rating and issued a $8.00 price target on shares of agilon health in a research note on Wednesday, August 7th. Finally, Citigroup reiterated a “sell” rating and issued a $2.50 price target (down from $7.00) on shares of agilon health in a research note on Tuesday, October 29th. Three equities research analysts have rated the stock with a sell rating, fifteen have issued a hold rating and two have given a buy rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $6.38.

agilon health Stock Up 0.8 %

Shares of NYSE AGL opened at $1.89 on Monday. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.29 and a current ratio of 1.29. agilon health has a 12 month low of $1.80 and a 12 month high of $13.76. The firm has a fifty day simple moving average of $3.18 and a two-hundred day simple moving average of $4.93.

agilon health (NYSE:AGL) last issued its quarterly earnings data on Thursday, November 7th. The company reported ($0.29) EPS for the quarter, missing the consensus estimate of ($0.10) by ($0.19). agilon health had a negative return on equity of 47.84% and a negative net margin of 6.88%. The company had revenue of $1.45 billion during the quarter, compared to the consensus estimate of $1.47 billion. During the same quarter last year, the company posted ($0.06) earnings per share. Equities research analysts expect that agilon health will post -0.35 EPS for the current year.

Insider Activity

In related news, CEO Steven Sell purchased 20,000 shares of the company’s stock in a transaction dated Thursday, September 12th. The shares were purchased at an average price of $3.36 per share, with a total value of $67,200.00. Following the acquisition, the chief executive officer now directly owns 67,590 shares in the company, valued at $227,102.40. The trade was a 0.00 % increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 3.20% of the company’s stock.

Institutional Trading of agilon health

A number of institutional investors have recently made changes to their positions in the stock. Vanguard Group Inc. boosted its holdings in shares of agilon health by 1.3% during the 1st quarter. Vanguard Group Inc. now owns 28,947,798 shares of the company’s stock valued at $176,582,000 after acquiring an additional 371,537 shares during the last quarter. Capital International Investors boosted its holdings in shares of agilon health by 84.7% during the 1st quarter. Capital International Investors now owns 20,197,932 shares of the company’s stock valued at $123,207,000 after acquiring an additional 9,263,296 shares during the last quarter. Citigroup Inc. boosted its holdings in shares of agilon health by 2,251.5% in the third quarter. Citigroup Inc. now owns 2,028,246 shares of the company’s stock worth $7,971,000 after buying an additional 1,941,993 shares during the last quarter. AQR Capital Management LLC grew its position in agilon health by 3,338.5% during the second quarter. AQR Capital Management LLC now owns 1,356,438 shares of the company’s stock valued at $8,871,000 after buying an additional 1,316,990 shares during the period. Finally, Bank of New York Mellon Corp grew its position in agilon health by 18.7% during the second quarter. Bank of New York Mellon Corp now owns 1,108,921 shares of the company’s stock valued at $7,252,000 after buying an additional 174,883 shares during the period.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.